Neurohormonal responses to cholecystokinin tetrapeptide: A comparison of younger and older healthy subjects

Psychoneuroendocrinology

Volumn 25, Issue 6, 2000, Pages 633-647

  Flint, Alastair J ^a   Koszycki, Diana ^a   Bradwejn, Jacques ^a   Vaccarino, Franco J ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Adrenocorticotropic hormone; Aged; Cholecystokinin tetrapeptide; Cortisol; Growth hormone; Prolactin

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; PLACEBO; PROLACTIN; TETRAGASTRIN;

ADULT; AGE; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PANIC; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; AGED, 80 AND OVER; AGING; DOUBLE-BLIND METHOD; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; MALE; PANIC DISORDER; PLACEBOS; PROLACTIN; TETRAGASTRIN;

EID: 0034131111     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(00)00015-9     Document Type: Article

References (10)

1. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed:1987;American Psychiatric Association, Washington (DC).
2. Bradwejn J. Neurobiological investigations into the role of cholecystokinin in panic disorder. Journal of Psychiatry and Neuroscience. 18:1993;178-188.
3. Bradwejn J., Koszycki D., Couetoux du Tertre A., van Megan H., den Boer J., Westenberg H., Annable L. The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder. Archives of General Psychiatry. 51:1994;486-493.
4. Charney D.S., Woods S.W., Nagy L.M., Southwick S.M., Krystal J.H., Heninger G.R. Noradrenergic function in panic disorder. Journal of Clinical Psychiatry. 51(12A):1990;5-11.
5. de Montigny C. Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Archives of General Psychiatry. 46:1989;511-517.
6. Flint A.J., Cook J.M., Rabins P.V. Why is panic disorder less frequent in late life? American Journal of Geriatric Psychiatry. 4:1996;96-109.
7. Flint A.J., Koszycki D., Vaccarino F.J., Cadieux A., Boulenger J-P., Bradwejn J. Effect of aging on cholecystokinin-induced panic. American Journal of Psychiatry. 155:1998;283-285.
8. Koszycki D., Zacharko R.M., Le Melledo J-M., Young S.N., Bradwejn J. Effect of acute tryptophan depletion on behavioral, cardiovascular, and hormonal sensitivity to cholecystokinin-tetrapeptide challenge in healthy volunteers. Biological Psychiatry. 40:1996;648-655.
9. Spitzer R.L., Williams J.B.W., Gibbon M., First M.B. Structured Clinical Interview for DSM-III-R - Non-Patient Edition (SCID-NP, Version 1.0). 1990;American Psychiatric Press, Washington (DC).
10. Timiras P.S. Physiological Basis of Geriatrics. 1988;Macmillan Publishing Co, New York.